adverse drug reaction (ADR)

From Aaushi
Jump to navigation Jump to search

Introduction

A harmful or inpleasant reaction resulting from an intervention related to a medicinal product, which predicts hazard of future administration & warrants prevention &/or specific treatment, alteration of drug dosage or discontinuation of a drug.

Etiology

Epidemiology

Complications

Management

Notes

  • see drug adverse effect or the drug itself for adverse effects of a specific drug or classes of drug
  • as a general rule, the drug would need to be administered at >= 3x the frequency of the adverse drug event to observe 1 event with 95% confidence; thus if frequency is 1%
    • probability of observance = 1 - (1 - frequency) exp (number of participants)
      • if 100 participants,

More general terms

More specific terms

Additional terms

References

  1. Pirmohamed M & Park BK, Toxicology 192:23-32, 2003
  2. 2.0 2.1 Loke YK at al, Case reports of suspected drug reactions - Systematic literature survey of follow-up BMJ 2006; 332:335 PMID: https://www.ncbi.nlm.nih.gov/pubmed/16421149
  3. 3.0 3.1 Budnitz DS et al. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011 Nov 24; 365:2002 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/22111719 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMsa1103053
  4. Onder G, Petrovic M, Tangiisuran B, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: The GerontoNet ADR Risk Score. Arch Intern Med 2010; 170(13):1142-1148 PMID: https://www.ncbi.nlm.nih.gov/pubmed/20625022
  5. FDA MedWatch program http://www.fda.gov/medwatch/report/hcp.htm
  6. Geriatric Review Syllabus, 7th edition Parada JT et al (eds) American Geriatrics Society, 2010
  7. 7.0 7.1 7.2 Medical Knowledge Self Assessment Program (MKSAP) 16, 18. American College of Physicians, Philadelphia 2012, 2018.
  8. 8.0 8.1 8.2 8.3 8.4 Shehab N, Lovegrove MC, Geller AI et al. US Emergency department visits for outpatient adverse drug events, 2013-2014. JAMA 2016 Nov 22/29; 316:2115 PMID: https://www.ncbi.nlm.nih.gov/pubmed/27893129
    Kessler C, Ward MJ, McNaughton CD. Reducing adverse drug events: The need to rethink outpatient prescribing. JAMA 2016 Nov 22/29; 316:2092. PMID: https://www.ncbi.nlm.nih.gov/pubmed/27893112
  9. FDA News Release. Sept 28, 2017 FDA improves access to reports of adverse drug reactions. New online tool makes it easier for users to search the FDA Adverse Event Reporting System. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm578105.htm
  10. Ferner RE. Adverse drug reactions in dermatology. Clin Exp Dermatol. 2015 Mar;40(2):105-9; PMID: https://www.ncbi.nlm.nih.gov/pubmed/25622648
  11. Darlenski R, Kazandjieva J, Tsankov N. Systemic drug reactions with skin involvement: Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS. Clin Dermatol. 2015 Sep-Oct;33(5):538-41. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/26321400
  12. FDA Adverse Events Reporting System (FAERS) Public Dashboard https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm070093.htm
  13. Hajjar ER, Hanlon JT, Artz MB et al Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother. 2003 Dec;1(2):82-9. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15555470